Alivus Life Sciences block deals, bulk deals and insider trading
NSE: ALIVUSBSE: 543322Pharmaceuticals & BiotechnologySmall Cap
Alivus Life Sciences Limited · Formerly Glenmark Life Sciences · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2021 · Issue price ₹720
Last close ₹1,415.30up ₹17.90 (1.28%)BSE ₹1,407.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,397.40.
30 Oct: open ₹1,451.00, high ₹1,499.00, low ₹1,380.00
52-week range of traded prices to 30 Oct 2026
₹819.00Low, 22 Jan 2026₹1,499.00High, 30 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17,376 Cr502nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.94
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.35%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 23.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,47,21334.5% delivered
Alivus Life Sciences' insiders have 79 trade disclosures on record, the latest on 7 Oct 2026. Its promoter group made no purchase or sale on the market in the 12 months to 30 Oct 2026.
Promoter and insider buying and selling
Trades made since 1 Nov 2025.Alivus Life Sciences promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Alivus Life Sciences insider trading
The company's own latest disclosure on record is from Jul 2024.Insider trading, all companies
Sep 2026
- Dr. Yasir Rawjee₹1.66 Cr12,300 sharesSold or invoked · Designated Person · 29 Sep 2026 · disclosed 7 Oct
- Dr. Yasir Rawjee₹0.86 Cr6,292 sharesSold or invoked · Designated Person · 28 Sep 2026 · disclosed 7 Oct
- Dr. Yasir Rawjee₹0.74 Cr5,199 sharesSold or invoked · Designated Person · 23 Sep 2026 · disclosed 4 Oct
- Dr. Yasir Rawjee₹0.03 Cr244 sharesSold or invoked · Designated Person · 22 Sep 2026 · disclosed 4 Oct
- Dr. Yasir Rawjee₹1.36 Cr9,617 sharesSold or invoked · Designated Person · 21 Sep 2026 · disclosed 4 Oct
- Dr. Yasir Rawjee₹4.11 Cr28,830 sharesSold or invoked · Designated Person · 18 Sep 2026 · disclosed 1 Oct
- Dr. Yasir Rawjee₹0.69 Cr5,000 sharesSold or invoked · Designated Person · 17 Sep 2026 · disclosed 1 Oct
- Dr. Yasir Rawjee₹1.03 Cr7,448 sharesSold or invoked · Designated Person · 16 Sep 2026 · disclosed 1 Oct
- Dr. Yasir Rawjee₹0.28 Cr2,046 sharesSold or invoked · Designated Person · 15 Sep 2026 · disclosed 30 Sep
- Dr. Yasir Rawjee₹1.37 Cr9,850 sharesSold or invoked · Designated Person · 4 Sep 2026 · disclosed 30 Sep
- Mihir Doshi₹0.07 Cr500 sharesSold or invoked · Designated Person · 3 Sep 2026 · disclosed 30 Sep
- Dr. Yasir Rawjee₹0.14 Cr1,000 sharesSold or invoked · Designated Person · 3 Sep 2026 · disclosed 30 Sep
- Dr. Yasir Rawjee₹1.15 Cr8,000 sharesSold or invoked · Designated Person · 2 Sep 2026 · disclosed 30 Sep
- Mihir Doshi₹0.29 Cr2,000 sharesSold or invoked · Designated Person · 1 Sep 2026 · disclosed 30 Sep
- Dr. Palle V R Acharyulu₹0.29 Cr2,025 sharesSold or invoked · Designated Person · 1 Sep 2026 · disclosed 30 Sep
- Dr. Yasir Rawjee₹1.83 Cr12,690 sharesSold or invoked · Designated Person · 1 Sep 2026 · disclosed 30 Sep
Aug 2026
- Dr. Yasir Rawjee₹4.25 Cr30,000 sharesSold or invoked · Designated Person · 31 Aug 2026 · disclosed 30 Sep
- Dr. Palle V R Acharyulu₹0.14 Cr1,000 sharesSold or invoked · Designated Person · 31 Aug 2026 · disclosed 30 Sep
- Anshu Razdan₹0.35 Cr2,500 sharesSold or invoked · Designated Person · 31 Aug 2026 · disclosed 30 Sep
- Dr. Yasir Rawjee₹1.11 Cr8,200 sharesSold or invoked · Designated Person · 28 Aug 2026 · disclosed 30 Sep
- Mihir Doshi₹0.20 Cr1,500 sharesSold or invoked · Designated Person · 28 Aug 2026 · disclosed 30 Sep
- Dr. Yasir Rawjee₹0.91 Cr6,685 sharesSold or invoked · Designated Person · 27 Aug 2026 · disclosed 30 Sep
- Mihir Doshi₹0.13 Cr1,000 sharesSold or invoked · Designated Person · 24 Aug 2026 · disclosed 30 Sep
- Amol M Kirtani₹0.14 Cr1,000 sharesSold or invoked · Designated Person · 21 Aug 2026 · disclosed 30 Sep
- Mihir Doshi₹0.06 Cr471 sharesSold or invoked · Designated Person · 21 Aug 2026 · disclosed 30 Sep
- Dr. Palle V R Acharyulu₹0.15 Cr1,089 sharesSold or invoked · Designated Person · 19 Aug 2026 · disclosed 30 Sep
- Dr. Palle V R Acharyulu₹0.37 Cr2,615 sharesSold or invoked · Designated Person · 17 Aug 2026 · disclosed 30 Sep
- Navin Kumar Agrawal₹0.14 Cr1,000 sharesSold or invoked · Designated Person · 14 Aug 2026 · disclosed 30 Sep
- Sachin Uttekar₹0.16 Cr1,150 sharesSold or invoked · Designated Person · 14 Aug 2026 · disclosed 30 Sep
- Dr. Palle V R Acharyulu₹0.45 Cr3,271 sharesSold or invoked · Designated Person · 12 Aug 2026 · disclosed 30 Sep
- Sachin Uttekar₹0.12 Cr850 sharesSold or invoked · Designated Person · 12 Aug 2026 · disclosed 30 Sep
- Sachin Uttekar₹0.01 Cr100 sharesSold or invoked · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- Sachin Uttekar₹0.27 Cr2,000 sharesBought · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- MATHEW GEORGE₹0.34 Cr2,500 sharesBought · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- Navin Kumar Agrawal₹0.55 Cr4,000 sharesSold or invoked · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- Anshu Razdan₹0.27 Cr2,000 sharesBought · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- Dr. Palle V R Acharyulu₹0.69 Cr5,000 sharesSold or invoked · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- Mihir Doshi₹0.48 Cr3,500 sharesBought · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- Navin Kumar Agrawal₹0.69 Cr5,000 sharesBought · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- Dr. Palle V R Acharyulu₹2.06 Cr15,000 sharesBought · Designated Person · 10 Aug 2026 · disclosed 30 Sep
- MATHEW GEORGE₹0.13 Cr1,000 sharesSold or invoked · Designated Person · 4 Aug 2026 · disclosed 30 Sep
- Navin Kumar Agrawal₹0.24 Cr2,000 sharesSold or invoked · Designated Person · 3 Aug 2026 · disclosed 30 Sep
- MATHEW GEORGE₹0.36 Cr3,000 sharesSold or invoked · Designated Person · 3 Aug 2026 · disclosed 30 Sep
Jun 2026
- Mr. Vinod Naik₹0.34 Cr3,000 sharesSold or invoked · Designated Person · 30 Jun 2026 · disclosed 3 Jul
- Mr. Vinod Naik₹0.11 Cr1,000 sharesSold or invoked · Designated Person · 24 Jun 2026 · disclosed 30 Jun
- Navin Kumar Agrawal₹0.14 Cr1,200 sharesSold or invoked · Designated Person · 23 Jun 2026 · disclosed 29 Jun
May 2026
- Navin Kumar Agrawal₹0.31 Cr2,900 sharesSold or invoked · Designated Person · 26 May 2026 · disclosed 25 Jun
- Anshu Razdan₹0.10 Cr1,000 sharesBought · Designated Person · 25 May 2026 · disclosed 30 May
- Navin Kumar Agrawal₹0.12 Cr1,100 sharesBought · Designated Person · 25 May 2026 · disclosed 30 May
Jan 2026
- Dr. Yasir Rawjee₹4.89 Cr52,000 sharesBought · Designated Person · 29 Jan 2026 · disclosed 7 Apr
- Navin Kumar Agrawal₹0.19 Cr2,000 sharesBought · Designated Person · 29 Jan 2026 · disclosed 7 Apr
Sep 2025
- Navin Kumar Agrawal₹0.20 Cr2,000 sharesSold or invoked · Designated Person · 19 Sep 2025 · disclosed 25 Sep
Aug 2025
4 entries
- Navin Kumar Agrawal₹0.21 Cr2,200 sharesBought · Designated Person · 28 Aug 2025 · disclosed 3 Sep
- Dr. Yasir Rawjee₹4.71 Cr50,000 sharesBought · Designated Person · 28 Aug 2025 · disclosed 3 Sep
- Mr. Sumantra Mitra₹0.20 Cr2,000 sharesSold or invoked · Designated Person · 5 Aug 2025 · disclosed 8 Aug
- Mr. Sumantra Mitra₹0.19 Cr2,000 sharesSold or invoked · Designated Person · 4 Aug 2025 · disclosed 8 Aug
May 2025
10 entries
- Mr. Sumantra Mitra₹0.31 Cr2,805 sharesSold or invoked · Designated Person · 23 May 2025 · disclosed 29 May
- Mr. Sumantra Mitra₹0.62 Cr5,601 sharesSold or invoked · Designated Person · 22 May 2025 · disclosed 28 May
- Mr. Sumantra Mitra₹0.11 Cr1,006 sharesSold or invoked · Designated Person · 21 May 2025 · disclosed 28 May
- Sachin Uttekar₹0.11 Cr1,000 sharesBought · Designated Person · 8 May 2025 · disclosed 14 May
- Navin Kumar Agrawal₹0.31 Cr2,800 sharesBought · Designated Person · 8 May 2025 · disclosed 14 May
- Mr. Vinod Naik₹0.44 Cr4,000 sharesBought · Designated Person · 8 May 2025 · disclosed 14 May
- Mr. Sumantra Mitra₹2.32 Cr20,950 sharesBought · Designated Person · 8 May 2025 · disclosed 14 May
- Mihir Doshi₹0.33 Cr2,966 sharesBought · Designated Person · 8 May 2025 · disclosed 14 May
- MATHEW GEORGE₹0.46 Cr4,190 sharesBought · Designated Person · 8 May 2025 · disclosed 14 May
- Dr. Yasir Rawjee₹5.53 Cr50,000 sharesBought · Designated Person · 8 May 2025 · disclosed 14 May
Mar 2025
1 entry
- Dr. Sukumar Sinha₹0.45 Cr4,190 sharesBought · Designated Person · 19 Mar 2025 · disclosed 25 Mar
Jul 2024
5 entries
- Glenmark Pharmaceuticals Limited₹45 Cr5,39,319 sharesSold or invoked · Promoter · 12 Jul 2024 · disclosed 1 Feb 2025
- GLENN SALDANHA₹0.65 Cr7,800 sharesGave · Promoter Group · 11 Jul 2024 · disclosed 15 Jul · Others · held 7,800 before
- Glenmark Pharmaceutical Limited₹798 Cr96,09,571 sharesGave · Promoters · 11 Jul 2024 · disclosed 15 Jul · Others · held 96,09,571 before
- Mr. GLENN MARIO SALDANHA₹0.21 Cr2,551 sharesSold or invoked · Promoter And Designated Person · 1 Jul 2024 · disclosed 1 Feb 2025
- Glenmark Pharmaceuticals Limited₹262 Cr31,42,675 sharesSold or invoked · Promoter · 1 Jul 2024 · disclosed 1 Feb 2025
Mar 2024
3 entries
- Nirma Limited₹1,467 Cr2,45,05,435 sharesReceived · Promoters · 12 Mar 2024 · Off Market · stake 55.00% before, 75.00% after
- Glenmark Pharmaceutical Limited₹1,465 Cr2,45,05,435 sharesGave · Promoters · 12 Mar 2024 · Off Market · stake 27.84% before, 7.84% after
- Glenmark Pharmaceuticals Limited₹4,030 Cr6,73,89,944 sharesGave · Promoters · 6 Mar 2024 · Off Market · stake 82.84% before, 27.84% after
Sep 2023
1 entry
- Glenmark Pharmaceuticals Limited₹591 Cr96,09,571 sharesPledged · Promoters · 21 Sep 2023 · disclosed 25 Sep · Others · stake 82.84% before, 82.84% after
Nov 2021
2 entries
- GLENN SALDANHA₹0.48 Cr7,505 sharesBought · Promoter Group · 16 Nov 2021 · disclosed 17 Nov · held 295 before, holds 7,800 after
- GLENN SALDANHA₹0.02 Cr295 sharesBought · Promoter Group · 15 Nov 2021 · disclosed 17 Nov · holds 295 after
Oct 2021
1 entry
- Mr. GLENN MARIO SALDANHA₹0.50 Cr7,800 sharesBought · Promoter And Designated Person · 8 Oct 2021 · disclosed 22 Nov
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Alivus Life Sciences block deals and bulk deals
Last 12 months, since 1 Nov 2025: 1 bulk deal, ₹84 Cr bought and none sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 4 Dec 20251 firm · ₹84 Cr bought · ₹0 soldNet bought ₹84 Cr
- BoughtICICI PRUDENTIAL MUTUAL FUNDBought 9,69,912 at ₹870.000.79% of the company₹84 Cr
Thursday 25 Jan 20242 firms · ₹12 Cr bought · ₹12 Cr soldNet nil
- SoldBNP PARIBAS ARBITRAGEBlock dealSold 1,51,173 at ₹799.550.12% of the company₹12 Cr
- BoughtSOCIETE GENERALEBlock dealBought 1,51,173 at ₹799.550.12% of the company₹12 Cr
Monday 9 Aug 20211 firm · ₹61 Cr bought · ₹0 soldNet bought ₹61 Cr
- BoughtPOLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUNDBought 8,36,000 at ₹732.55₹61 Cr
Friday 6 Aug 20211 firm · ₹73 Cr bought · ₹73 Cr soldNet sold ₹0.03 Cr
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 9,51,097 at ₹765.77Sold 9,51,097 at ₹766.12Net nil₹73 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 5 deals on record since listing on 6 Aug 2021.